These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 637616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Electrophysiologic, antiarrhythmic and hemodynamic effects of transcainide.
    Carmeliet E, Janssen PA, Heykants J, Niemegeers CJ, Remeysen P, Van De Water A, Van Gerven W, Wauquier A, Xhonneux R.
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):272-90. PubMed ID: 3632145
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the antiarrhythmic activity of quinidine and quinine.
    Klevans LR, Kelly RJ, Kovacs JL.
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.
    Wascher TC, Dittrich P, Kukovetz WR.
    Arzneimittelforschung; 1991 Feb; 41(2):119-24. PubMed ID: 2043172
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lorcainide (R 15 889), a first review.
    Amery WK, Heykants JJ, Xhonneux R, Towse G, Oettel P, Gough DA, Janssen PA.
    Acta Cardiol; 1981 Feb; 36(3):207-34. PubMed ID: 7020313
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP, Stump GL, Yagel SK.
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
    [Abstract] [Full Text] [Related]

  • 14. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML, Stone CA, Wenger HC, Evans R, Lagerquist B, O'Malley T.
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
    Lynch JJ, Wallace AA, Stupienski RF, Baskin EP, Beare CM, Appleby SD, Salata JJ, Jurkiewicz NK, Sanguinetti MC, Stein RB.
    J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacology of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (Propafenone, SA 79)-hydrochloride].
    Hapke HJ, Prigge E.
    Arzneimittelforschung; 1976 May; 26(10):1849-57. PubMed ID: 1037204
    [Abstract] [Full Text] [Related]

  • 18. Hypotensive and antiarrhythmic effects of a new alkaloid, the 13-hydroxylupanine-2-pyrrolcarbonic acid ester, from the Madagascan plant Cadia ellisiana.
    Lindner E, Kaiser J, Schacht U.
    Arzneimittelforschung; 1976 May; 26(9):1651-7. PubMed ID: 11808
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y, Kawada M, Sawanobori K, Sonoki H, Inoue K, Mizuno K, Itou T, Tabunoki Y, Tsukamoto M, Ohashi Y, Kyotani Y, Shimizu N, Fujii M, Nakamura M.
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.